Similar articles

• Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

  Pérez-Jacoiste Asín MA, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Tejido Á, San Juan R, Arrebola-Pajares A, Lizasoain M, Prieto S, Aguado JM. Pérez-Jacoiste Asín MA, et al. Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119. Medicine (Baltimore). 2014. PMID: 25398060 Free PMC article. Review.
• [Calmette-Guerin bacillus disseminated infection after intravesical instillation].

  Borré S, Brustia D, Rosa F, Brondolo R, Rizzo G, Garavelli PL. Borré S, et al. Recenti Prog Med. 2002 Apr;93(4):247-8. Recenti Prog Med. 2002. PMID: 11989131 Review. Italian.
• BCG sepsis following inadvertent intravenous BCG administration for the treatment of bladder cancer can be effectively cured with anti-tuberculosis medications.

  Akbulut Z, Canda AE, Atmaca AF, Cimen HI, Hasanoglu C, Balbay MD. Akbulut Z, et al. N Z Med J. 2010 Nov 5;123(1325):72-7. N Z Med J. 2010. PMID: 21317964
• An unexpected complication of bacillus Calmette-Guérin therapy.

  Yildiz H, Colin G, Lambert M. Yildiz H, et al. Acta Clin Belg. 2014 Aug;69(4):312. doi: 10.1179/2295333714Y.0000000032. Epub 2014 May 20. Acta Clin Belg. 2014. PMID: 24846180 No abstract available.
• BCG pyelonephritis following intravesical therapy for transitional cell carcinoma.

  Garcia JE, Thiel DD, Broderick GA. Garcia JE, et al. Can J Urol. 2007 Apr;14(2):3523-5. Can J Urol. 2007. PMID: 17466161